Hence, BPC-157 is clearly on the do not compound for human use list
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System, Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I, Pharmaceuticals (Basel), Pharmaceuticals, 2025 Jun 19;18(6):928
Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS
Food and Drug Administration (FDA) advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to remain strong
Each model replicates different aspects of human gastroparesis pathology inflammatory injury, vascular dysfunction, neuropathy allowing researchers to test BPC-157s effects across multiple etiological mechanisms
